October 30, 2025, Medical Economics
AI, Malpractice, and the Future of Physician Liability
Artificial intelligence (AI) is entering everyday care, raising questions about malpractice. Deepika Srivastava, Chief Operating Officer at The Doctors Company, discusses how AI could redefine the standard of care, what happens when an algorithm contributes to patient harm, and practical steps physicians can take now to protect themselves—including documentation, communication and clear internal policies.
Search
June 02, 2023, Cardiology Magazine
Lessons From Medical Malpractice Claims
Experts from The Doctors Company review a cardiology malpractice case involving improper management of warfarin, examining the key elements of the case to identify risk mitigation strategies.
Dec 02, 2024
2024 Judicial Review: Significant Court Decisions on Medical Liability Issues
Between fall 2023 and summer 2024, state supreme courts handed down mixed decisions on medical liability issues affecting healthcare professionals.
From
The Doctor’s Advocate
December 01, 2022, Healthcare Risk Management
Remember the Basics of Good Documentation
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, provides suggestions for executing good documentation practices to accurately record patient encounters.
Sep 05, 2025
The Foundation Board Welcomes New Director Ami Parekh, MD, JD
We’re pleased to welcome Ami Parekh, MD, JD, to The Doctors Company Foundation Board of Directors. Dr. Parekh is the Chief Health Officer at Included Health, where she leads their national primary care, urgent care, behavioral health, clinical navigation, and population health management practices.
From
The Doctor’s Advocate
September 01, 2023, Part B News
Head Off Problem Patients With Signed Agreements, Legal Review: Expert
Richard F. Cahill, Esq., Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses the rights and responsibilities of practice managers who wish to remove or stop admitting troublesome patients.
January 31, 2022, Medscape
Medscape Ob/Gyn Malpractice Report 2021
Peter Kolbert, JD, Senior Vice President of Claim and Litigation Services for Healthcare Risk Advisors, part of TDC Group, notes why ob/gyn carries significant financial exposure with lawsuits.
Aug 27, 2024
Industry and Company News Third Quarter 2024
Announcements in the third quarter 2024 include recognition for our Claims team, a new article by Bob White featured in Fortune, and affirmation of our commitment to health workforce well-being.
From
The Doctor’s Advocate
May 11, 2023, Inside Medical Liability Online
Postpartum Malpractice Claims: Can We Understand Preventable Harms and Socioeconomic Factors?
Rates for maternal morbidity and mortality are higher in the U.S. than in any other developed country—and many of the harms suffered by patients are preventable. In a multifactorial study, David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group; Jacqueline Ross, PhD, RN, CPAN, Coding Director, Department of Patient Safety and Risk Management, The Doctors Company, and Shelise Valentine, RNC, MSN, Director of Clinical Education, Healthcare Risk Advisors, part of TDC Group, investigated postpartum claims to develop clinical recommendations to decrease the risks of postpartum morbidity and mortality.
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
